Intracoronary infusion of mononuclear cells from bone marrow or peripheral blood compared with standard therapy in patients after acute myocardial infarction treated by primary percutaneous coronary intervention: results of the randomized controlled HEBE trial

Alexander Hirsch, Robin Nijveldt, Pieter A. van der Vleuten, Jan G. P. Tijssen, Willem J. van der Giessen, Rene A. Tio, Johannes Waltenberger, Jurrien M Ten Berg, Pieter A. Doevendans, Wim R. M. Aengevaeren, Jaap Jan Zwaginga, Bart J. Biemond, Albert C. van Rossum, Jan J. Piek*, Felix Zijlstra

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

144 Citations (Web of Science)
Original languageEnglish
Pages (from-to)1736-1747
JournalEuropean Heart Journal
Issue number14
Publication statusPublished - Jul 2011


  • Cell therapy
  • Myocardial infarction
  • Magnetic resonance imaging
  • Left ventricular function
  • Remodelling

Cite this